The University Hospital Center of Treichville is a hospital in Abidjan, Ivory Coast. The facility was built in 1938 to be an annex hospital of the nearby Plateau Central Hospital. In 1976 the facility acquired the status of university hospital center.

During the past decade, Centre de Prise en Charge et de Formation (CePReF), Association ACONDA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Prise en Charge et de Formation (CePReF), Association ACONDA" #1 collaborator was "Mylan Laboratories" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Prise en Charge et de Formation (CePReF), Association ACONDA" are "HIV Infection" (1 trials), "HIV-1-infection" (1 trials) and "HIV-2 Infection" (1 trials). Many other conditions were trialed in "Centre de Prise en Charge et de Formation (CePReF), Association ACONDA" in a lesser frequency.

Most popular intervention types in "Centre de Prise en Charge et de Formation (CePReF), Association ACONDA" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)" (1 trials), "Lamivudine" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Raltegravir" (1 trials) and "Tenofovir + Emtricitabine or Lamivudine + Zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Prise en Charge et de Formation (CePReF), Association ACONDA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centre de Prise en Charge et de Formation (CePReF), Association ACONDA". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre de Prise en Charge et de Formation (CePReF), Association ACONDA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Prise en Charge et de Formation (CePReF), Association ACONDA, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".